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Towards A Model-Based Systems Engineering
Approach To Life-Science Instrumentation Systems
Development
Franc¸ois Patou, Maria Dimaki, Anja Maier , Winnie E Svendsen and Jan Madsen
Abstract
Next-generation genome sequencing machines and Point-of-Care in vitro diagnostics devices are precursors of an emerging
class of Cyber-Physical Systems, one that harnesses biomolecular-scale mechanisms to enable novel “wet-technology” applications
in medicine, biotechnology and environmental science. Although many such applications exist, testifying the importance of
innovative life-sciences instrumentation, recent events have highlighted the difficulties that designing organisations face in their
attempt to guarantee safety, reliability and performance of this special class of Cyber-Physical Systems. New regulations and
increasing competition pressure innovators to rethink their design and engineering practices, and to better address the above
challenges. The pace of innovation will be determined by how organisations manage to ensure the satisfaction of aforementioned
constraints while also streamlining product development, maintaining high cost-efficiency and shortening time-to-market.
Model-Based Systems Engineering provides a valuable framework for addressing these challenges. In this paper, we demon-
strate that existing and readily-available model-based development frameworks can be adopted early in the life-sciences instrumen-
tation design process. Such frameworks are specifically helpful in describing and characterizing Cyber-Physical Systems including
elements of a biological nature both at the architectural and performance level. We present the SysML model of a smartphone-based
Point-Of-Care diagnostics system designed for detecting a particular molecular marker. By modelling components and behaviours
spanning across the biological, physical-non-biological and computational domains, we were able to characterize the important
systemic relations involved in the specification of our system’s Limit-Of-Detection. Our results illustrate the suitability of such
an approach and call for further work towards formalisms enabling the formal-verification of systems including biomolecular
components.
Index Terms
Cyber-Physical Systems; Life-Science; Model-Based Systems Engineering; Model-Based Systems Design; SysML; Sensitivity
analysis
I. INTRODUCTION
Many advances in health, sustainability, and security depend on our ability to integrate emerging life-science technologies
into complex Cyber-Physical Systems (CPS). The personalization of medicine and the scaling-up of air, water and soil quality
monitoring are examples of application domains where progress is conditioned by our capacity to interface with the molecular
micro-environment. Advances in biochemistry and synthetic biology give rise to as many powerful applications as their
compositions with distributed computing or Artificial Intelligence (AI) allow. From the sequencing and interpretation of our
genome [1], to the automated synthesis of de novo biopolymers such as DNA, RNA or proteins [2], [3], the spectrum of
possibilities offered by systems spanning life-science, mechatronics and information technologies is immense. Novel molecular
diagnostic and genomic technologies, for instance, challenge the current in vitro medical testing (IVMT) paradigm by offering
progressively decentralized and self-diagnostics capabilities to lay-users, thereby promoting disruptive care models where
patients are empowered to contribute more directly to their own health management [4]–[6]. Meanwhile, new tools in synthetic
biology make it continuously easier to translate digital information into biological entities, to (re-)program life, and to gradually
blur the boundaries that have so far separated the Natural from the Artificial [2], [3], [7].
Yet, the disruptive potential of these applications seems to have brought as much hope and excitement as it has sourced
concern. The pressing character of ethical issues related to the decentralization and democratization of DNA synthesis tech-
nologies, for instance, is widely agreed upon [8]. Likewise, recent scandals in the field of in vitro diagnostics testing have led
to skepticism among experts and lowered public trust in manufacturers’ ability to guarantee the safety and efficacy of CPS
systems that peek into our blood [9], [10]. These rising ethical and safety concerns will likely drive the tightening of current
IVMT and biosynthesis equipment manufacturing regulatory frameworks, which may in turn hinder the pace of innovation in
these areas so critical for both our economy and quality of life. Confronted with more stringent requirements of all kinds,
designing organisations have no choice but to seek for better adapted engineering practices. Such practices should ensure the
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development of safe, reliable and high-performing CPS based on life-science technologies, help these organisations demonstrate
that development efforts were pursued according to best practices, and at the same time favour cost-efficiency and shorten
time-to-market.
We will refer to this class of systems tightly interfaced with the biomolecular environment as Cyber-Biological and -Physical
Systems (CBPS). As such, CBPS encompass in vitro medical testing equipment [4], [5], but also in vivo molecular sensing
devices [11], [12] and DNA synthesizers [2], [3], [13].
Facing a dynamic, highly-regulated and competitive environment and challenged by an increasing level of product complexity,
CBPS-developing organisations possess all the characteristic incentives that call for the adoption of Model-Based Systems
Engineering (MSBE) practices. Model-Based Systems Design (MBSD) in particular, has been leveraged in many industrial
domains to streamline the systems engineering effort from early analysis and specification to implementation, verification
and validation by confining early system development in silico. MBSD thus aims to reduce the risks of implementation, to
ensure requirement satisfaction, to promote overall value-efficiency, and to facilitate the management of and innovation within
product-families [14].
We demonstrate in this paper that generic tools and frameworks of MBSD readily support holistic design and development
of Cyber-Biological and -Physical Systems. More specifically, we demonstrate that readily-available model-based development
frameworks can be used to model and analyse Cyber-Physical Systems including elements of a biological nature both at the
architectural and performance level: we present the multi-domain modelling and simulation capabilities associated with System
Modelling Language (SysML) and illustrate its relevance for assessing CBPS’ performance metrics influenced by elements
of biological, physical-non-biological, and computational nature. In particular, we discuss a molecular diagnostics system,
engineered around the Silicon-Nanowire biological Field-Effect Transistor (SiNW-bioFET) technology. We build and harness
a SysML model of this diagnostics system and carry out the parametric performance analysis of its Limit of Detection (LoD)
for a specific biomolecular target.
II. CYBER-BIOLOGICAL AND -PHYSICAL SYSTEMS
A. Properties of Cyber-Biological and -Physical Systems
Cyber Physical Systems (CPS) are defined as systems offering integrations of computation, networking and physical processes
[15]. CPS thus exhibit both elements of software and elements of a physical nature closely interacting with one another. Essential
for their purpose is the ability of a CPS to encode the physical reality experienced by its physical structures into palpable
information for its cyber- constituents, the latter being generally responsible for analyzing and supporting decision-making
through digital computations. Reciprocally, some of the commands and computational results issued from the cyber-elements
may be communicated and translated back to the physical elements of the system in order to influence the physical world in a
prescribed manner. Computations and control are generally achieved with a high degree of automation, which in turn requires
that CPS implement networking and cyber-physical integrations over multiple temporal and spatial scales [16]. Sensors and
actuators are therefore pivotal to CPS: they provide the interfaces, i.e. the junctions that close the control loops that enable
CPS to influence the physical world in the way they are intended to.
Cyber-Biological and -Physical Systems, like CPS, behave according to multiple physics. They are yet generally more
heterogeneous than conventional CPS and their complexity space is often of higher dimensionality, the heterogeneity of the
engineering domains they encompass often meeting additional socio-technical, regulatory, and ethics challenges. Importantly,
CBPS form a specialized class of CPS for which sensing and actuation require the consideration of structures and processes
at the biomolecular level, especially when they influence overall system functionality and performance in a significant manner.
We elaborate on this particular attribute.
Chemical and biological sensing are usually at the core of CBPS functionality. Biological sensing (biosensing), more
specifically, underpins all the molecular diagnostics techniques of in vitro biochemical analysis, genome sequencing, as well
as a growing number of in vivo monitoring applications [12]. Biosensing mechanisms may be derived from a wide panel of
biophysical principles, with the objective to efficiently transduce information of biophysical nature into an alternative form
more easily readable by conventional instrumentation, e.g. optical or electrochemical to name a few. Actuation involving
biological components represents the other pillar of CBPS specialization. CBPS actuators comprehend an increasingly wide
range of technologies, still mostly based on engineering at the micro- or higher dimensional scales. There, their design and
fabrication remain manageable while providing sufficiently accurate physical behaviours to accommodate the most advanced
CBPS applications we know of today. Digital Microfluidics (DMF) for instance, allow the discrete manipulation of liquid
droplets containing relevant biomolecules on a 2D electrode array by using high electric potentials [17]. The digital nature of the
DMF enables the reconfiguration of fluid processing steps depending on the application at hand, for instance to program different
reagents and sample mixing protocols, droplet splitting, dilutions, or washing [18]. DMF has demonstrated its potential in a
wide range of life-science applications, including detection by immunoassay, Polymerase Chain Reaction (PCR), proteomics,
sample preparation for single-cell studies [19], or single-molecule extraction and analysis [20].
Sensing and actuation are thus critical articulation nodes for Cyber-Biological and -Physical Systems and play a fundamental
role in determining overall CBPS utility and value-effectiveness.
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B. Vertical integration in Cyber-Biological and -Physical Systems
Cyber-Biological and -Physical Systems are essentially engineered via the aggregation and interfacing of components issued
from chemistry, synthetic biology, nanotechnology, microfluidics, and optics, together with electronics, mechanics, embedded-
and application-software, cloud computing, and AI. CBPS systems engineers may therefore need to address a deeper vertical
integration for CBPS applications than for any other conventional CPS. Additionally, the emergence of synthetic biology is
bringing a myriad of new opportunities and challenges for the development of CBPS and marks a cornerstone in the history
of engineered systems. It does so by blurring the boundaries between the natural and artificial world and also from a system
architecting perspective, opening up new functional allocation schemes for CBPS design: biosensing, for instance, can now be
performed via the reengineering of bacterial genome rather than by the patterning of microstructures and immobilization of
organic molecules on silicon substrates [21]. Another example is the ever-more realistic scenario of DNA becoming a viable
digital information storage media [22]. Such revolutions clearly require new design frameworks and methodologies supporting
the complexity inherent to the deep integrations that next-generation CBPS will exhibit. That complexity may be further
increased by humans in the loop whenever CBPS operation is not fully automated, requiring the additional consideration of
user-system interactions or work process flows. Central clinical laboratories currently constitute one of the best examples of
an environment where this latter point is essential for ensuring overall system safety, efficacy and cost-efficiency.
III. MODEL-BASED SYSTEMS ENGINEERING FOR LIFE-SCIENCES INSTRUMENTATION DEVELOPMENT
Extending the practice of conventional Systems Engineering (SE), MBSE aims to formalize the development of systems
through the use of models. Rumbaugh et al. suggest that any model defines a “representation of a selected part of the
world, the domain of interest, that captures the important aspects, from a certain point of view, simplifying or omitting the
irrelevant features” [23]. MBSE consists of a set of formalisms and practices that leverage these representations throughout
the systems engineering life cycle in order to support the delivery of value-effective systems [24]. It does so essentially by
enabling efficient management of system complexity, mitigation of risks and assessment of requirement satisfaction via virtual
prototyping. Model-Based System Design (MBSD), which encompasses all MBSE design-related activities, intends to harness
models from early system analysis and specification, to design, implementation and testing, verification, and validation. MBSE
and MBSD commonly rely on graphical modelling capabilities, addressing the need for communication between stakeholders
of various backgrounds.
MBSE practices have matured together with information technology, progressively enabling systems architects and engineers
to abandon traditional document-based SE to embrace a model-based approach to system design and development. MBSE
has thus followed the footsteps of some of the traditional engineering disciplines it spans, such as mechanical or electrical
engineering. MBSE has been adopted in a variety of application domains, from defence and aerospace to energy systems and
transportation where the scale and complexity of systems and infrastructures keeps growing [25]. MBSE has only relatively
recently been acknowledged as a potential vector for the development of value-efficient systems in healthcare. In particular,
MBSE appeals for its formalism and the potential for standardizing a number of healthcare system development processes
and medical systems architectures. Ongoing research is for instance ascertaining the potential of MBSE for developing high-
assurance system software, for favoring interoperability, context-aware intelligence, autonomy, security and privacy, and for
supporting device certifiability of life-critical, context-aware networks of medical devices [26]. Khayal et al. also recently
underlined the value of MBSE in clinical practice in general, and in functional medicine in particular [27].
We see great potential in using MBSD for the development of Cyber-Biological and -Physical Systems. Supporting our
vision are the encouraging early demonstrations of applicability of existing system modelling tools to the life-science domain.
Somekh et al. for instance, have shown that Object-Process Modelling (OPM), a language typically used for engineered system
modelling, could be harnessed for hypothesis generation in systems-biology [28]). Such results suggest that the development
of systems spanning life-sciences, mechatronics, and information technologies readily possesses constructs and semantics to
describe the biological elements of CBPS. This in turn ties the successful embrace of MBSD for life-science instrumentation
development to two main challenges: missing integrations between domain-specific modelling tools and the lack of MBSD
methodologies adapted to the CBPS development context.
The objectives of MBSD for CBPS development remain the same as for conventional system design: to reduce development
time and associated costs. The amplitude of these benefits could yet be substantially higher in the former case, since the sole
development time and costs associated to the biological domain are usually significantly higher than those associated with
hardware or software. One way MBSD can limit these expenditures is by enabling better identification and characterization of
system-level interactions bridging the biological domain with the field of instrumentation, embedded systems and AI. As we
discussed in section II-B, these interactions (especially those at the low biological-physical-hardware level) and the interfaces
defining them usually play a pivotal role in determining overall system functionality, safety, efficacy and/or cost-efficiency. CBPS
development, perhaps more than most other kinds of systems, thus requires the availability of holistic modelling frameworks
supporting their vastly heterogeneous nature, the concurrence of their different cyber- biological- and physical processes, and
their potential real-time requirements.
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Fig. 1. Schematic of the Modular Diagnostic platform. The Hardware Accessory (HWA) is the pivotal element of the system, embedding the instrumentation
and control units necessary to operate various Lab-on-Chips (LOC). Here it interfaces to an Apple iPhone 6 over Bluetooth. A LOC embedding a Silicon
Nanowire biological Field Effect Transistor (SiNW-bioFET) is plugged to the front-end of the HWA. The gate of the SiNW-bioFET is coated with a ABL-kinase
receptor, targeting ATP molecules in solution.
IV. SYSML-BASED MBSD OF CYBER-BIOLOGICAL AND -PHYSICAL SYSTEMS
The System Modelling Language (SysML) is one of the most institutionalized systems modelling tools to this day. SysML
is a general-purpose language developed by the Object Management Group (OMG) as an extension of the Unified Modelling
Language (UML), the latter of which quickly became an industry standard for software design and analysis after the emergence
of object-orientation in computing in the 1970’s [24], [29]. SysML was meant to address the limitations of software-specific
UML and to allow the modelling of multi-domain large engineering systems [30]. SysML is not bound to a specific system
development framework, which has probably contributed to its institutionalization and growing acceptance.
Originally lacking clear semantics and being associated with a steep learning curve, SysML has suffered much criticism [31].
Although limitations of the OMG language encouraged the development of alternative systems modelling languages (e.g. Object-
Process Modelling (OPM) [32]), many research institutions and industries have relied on SysML to assist the development of
systems of various size and complexity. Many of these projects are still rooted in defence and aerospace [33]–[36]. As we
will see in the ensuing section, more recent initiatives have demonstrated the further potential of SysML for the development
and management of mechatronic or Cyber-Physical Systems (CPS). SysML recently benefited from the standardization of the
foundational UML (fUML) specification, which has strengthened its execution semantics and hence enhanced its integration
and simulation-related capabilities. SysML has been integrated both with domain-specific simulation environments (e.g. Matlab)
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Fig. 2. SiNW-bioFET LoD and system-level LoD
and various model repositories (e.g. Product Lifecycle Management tools). Early SysML integration endeavours focused on
establishing links between SysML abstract models on the one hand, and existing domain-specific executable models on the
other hand (e.g. [37], [38]). More recent works have however strived towards the synthesis of executable domain-specific
simulation code directly from abstract SysML models [39]. These integrations are possible thanks to the use of meta-modelling
languages enabling the translation of domain-specific SysML profiles to specific simulation environments (e.g. Modelica,
DEVS, etc.). These tools have allowed, in particular, purely discrete systems such as embedded real-time applications to be
fully conceptualized at the abstract SysML level, to be translated to simulation code [40], to be formally verified [41], and
eventually, in-part, to be synthesized to machine code [42], [43]. A review of the state of the art in executable SysML models
is proposed in [39].
The MBSD of CPS also necessitates ways of representing the continuous laws that govern the behaviour of the physical
elements of CPS. The biological processes pivotal to the functions and performances of CBPS, for instance, may demand
the capacity to specify and resolve partial differential equations, or as an alternative, to circumvent that issue by abstracting
time-dependent behaviours to simpler parametric relationships. Several MBSD approaches and tools have been proposed to
handle the modelling and simulation of physical- or hybrid CPS sub-systems. Recently, Karban et al. carried out requirement
verification for a large telescope using SysML [44]. The authors relied on parametric diagrams to establish the mathematical
relationships between the system’s most relevant variables, and on a variety of behavioral diagrams to establish an event-
based model of all the discrete processes involved in the operation of the system. Leserf et al. [45] recently re-acknowledge
the importance of comprehensive MBSE frameworks and modelling tools for exploring the CPS design space. The authors
proposed a SysML-based multi-domain optimization tool which they used to model of drone-like system.
In the ensuing section we present how SysML can support the early design and analysis of CBPS. After briefly introducing
a specific CBPS we developed in-house, we detail how SysML was used to support design choices. We specifically elaborate
on our case to determine effective system configurations using a system-wide parametric study spanning across the biological,
electronic and digital computation domains.
V. CASE: NANOWIRE BIOSENSOR AND INSTRUMENTATION SYSTEM FOR MEASURING ATP LEVELS IN SOLUTION
We undertook the MBSD of a biosensing platform introduced in [46]. Our Modular Diagnostics platform aims to allow the
detection of various biological molecular markers at Point-of-Care (POC), i.e. field medical diagnostics. It is built around a
Hardware Accessory (HWA) embedding several electronic instrumentation modules, and can be interfaced wirelessly to Apple
mobile devices (e.g. iPhone, iPad). Different Lab-on-Chip (LOC) devices, embedding a variety of biosensors, can in turn be
interfaced with the HWA (figure 1). This modular design theoretically allows for a wide panel of molecular targets to be
addressable by the same platform via the use of disposable LOC devices. An essential requirement of the first prototype of this
system was to accommodate for the Silicon Nanowire biological Field Effect Transistor (SiNW-bioFET) sensing technology.
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We discussed extensively the SiNW-bioFET as well as the instrumentation technique we chose for recovering its signals in
Patou et al. [47].
Derived from the common MOS-FET technology, the SiNW-bioFET supports the detection of specific biological targets by
presenting a selective biofunctional molecular layer at the surface of its gate (left of figure 2). This interface layer enables the
selective binding of circulating target molecules present in the biological sample (e.g. blood, saliva). The electric charges borne
by these targets should in turn influence the conductivity of the semiconducting channel of the device. In this case example
we consider the gate coated with the ABL-tyrosine-kinase receptor, specific to the ATP ligand. The ATP molecule has a
pivotal role in cell metabolism. As ATP molecules bind to ABL tyrosine-kinase receptors at the gate, variations in conductivity
within the semiconductor occur. This interaction principle is illustrated to the left in figure 2: the baseline current signal for
the SiNW-bioFET corresponds to the current running through the SiNW when no analyte is present in the sample. Spikes
of increasing concentrations of target biomarker should result in changes from that baseline, translating the building up of
markers binding to the SiNW-bioFET gate surface. The effectiveness of the biochemical processes responsible for transducing
the biochemical signal of targets at the gate into a form readable by the instrumentation determines the sensitivity of the assay.
Several electrical instrumentation techniques can be used to recover these signal variations. We consider the lock-in ampli-
fication method, also known as phase-sensitive detection [48]. The working principle of the lock-in amplifier is symbolically
illustrated to the right of figure 2. In the ideal scenario, sensor and instrumentation are well matched so that the instrumentation
can sensitively recover the signal variations at the sensor’s terminals without degrading signal quality. This scenario corresponds
to the illustration at the top-left of figure 2: an ideal instrumentation would allow the recovery of a concentration of target
biomarker generating a signal change from baseline as low as three times the Root Mean Square (RMS) noise level present in
the signal: this limit is called Limit-of-Detection (LoD). The LoD is an essential performance metric for in vitro diagnostics
instrumentation as it defines the minimum quantity of target biomarker that can be detected with a given confidence level.
The lower the LoD, the more likely one is to be able to ascertain the presence of low amounts of certain molecular disease
markers, which in turn may help establishing a diagnosis earlier, initiate timely treatment and promote better odds of recovery.
In the ideal (i.e. show to the left in figure 2) scenario, the LoD corresponds to one arbitrary unit of target biomarker.
The ideal scenario does not account for the intrinsic-noise generated by the instrumentation itself or by the extrinsic-noise
the system may pick up from the environment. The lock-in amplifier, although specifically designed for high-noise rejection,
will inevitably add some spurious components to the effective SiNW signal. Since SiNW-bioFETs generally output very low-
amplitude signals, the noise added by the instrumentation may well represent a significant proportion of the overall signal,
therefore impeding the overall LoD of the assay [47]. This realistic scenario is illustrated on the top-right corner of figure
2. The noise issued from the lock-in amplifier raises the overall noise level in the baseline signal. This means that a signal
generated by a concentration of biomarker corresponding to the LoD in the ideal case would be drowned in noise in a real case
scenario. Only signal changes larger than three times the RMS value of the inflated non-ideal case noisefloor can effectively
be detected: the system LoD will inevitably be higher than that of the sensor alone. This scenario is illustrated to the right
in figure 2, where the LoD roughly corresponds to two arbitrary units of target biomarker, versus one where instrumentation
would have been ideal.
Assay-instrumentation interactions must hence be established thoroughly in order to determine the trade-offs enabling
satisfaction of the LoD requirements while striving for both design effectiveness and efficiency. These analyses have profound
implications since they may, for instance, help determining whether engineering efforts and budgets should be allocated to
the development of costly biochemical assays or rather to the design or upgrade of an instrumentation whose development
costs may well differ by orders of magnitude. We present in the ensuing section how we pursued the early MBSD of our
SiNW-bioFET/HWA/iPhone system. We used SysML for a sensitivity analysis of our LoD performance metric for the detection
of ATP.
A. Methods
We used the NoMagic MagicDraw software suite to model our SiNW-bioFET/instrumentation system in SysML.
1) Stereotypes: Under the SysML profile, we started by defining stereotypes reflecting the various physical or engineering
domains one can expect to be represented in CBPS. More specifically, we differentiated Biological sub-systems from Hardware
(HW) sub-systems, Software (SW) sub-systems and from Mixed sub-systems, the latter relating to any combination or
hybridization of the first three.
Using these stereotypes, we first modelled the system structures we assumed would play a role in determining the LoD
specification (figure 3).
2) Structures: The biological sample, the LOC, and the HWA represent the three principal sub-systems involved in the
determination of the system LoD. Out of those three sub-systems only the LOC and HWA are engineered: the biological
sample is pre-existing and considered an input to the system. Yet, the abstraction of the biological sample leads to a hierarchy
of elements just like the decomposition of the Lab-On-Chip and Hardware Accessory do. We thus strived to decompose each
of these three sub-systems down to the highest level of abstraction that would allow capturing the most elementary properties
influencing the system LoD.
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TABLE I
INITIAL SYSTEM SPECIFICATIONS
Engineering Domain Component Specification Value
Microfabrication
Silicon Nanowire
Length 100× 10−6 m
Width 400× 10−9 m
Thickness {20 : 90× 10−9 m}
Carrier mobility 2 cm2/V s
Boron doping 1× 1024 m−3
Stray capacitance 1× 10−13 F
Gate
Material AlO2
Thickness {2 : 5× 10−9 m}
Surface chemistry
Receptor ABL Tyrosine-kinase
Receptor projection area 3× 10−17 m2
Receptor charge —
Receptor density {6.5 : 100× 1014 m−2}
Ligand ATP
Ligand projection area 3× 10−17 m2
Ligand charge −3 e
Charge-surface distance 2.4 nm
— Biological sample
Ionic strength 1× 10−12 mol m−3
Temperature 298 K
ATP concentration VAR
Electronics
Excitation
Frequency 20 Hz
Amplitude 0.3 V
Transimpedance Amplifier
Opamp AN8608
GBW 1× 107 Hz
Ccm 8× 10−12 F
Cdiff 2.2× 10−12 F
Inoise {1 : 1000× 10−11 A/
√
Hz}
ev 8× 10−9 V
√
Hz
Rf {1 : 10× 106 Ω}
Cf 1.5× 10−11 F
RC Driver
RS 1× 103 Ω
CS 1× 10−9 F
Resolution {12 : 14 bits}
Signal Processing
Analog-to-Digital Converter Sampling frequency 4× fs
Input span 3.3 V
AC-Coupling Output offset error —
Demodulation Frequency 20 Hz
FIR Filtering FIR Filter {34 : 856 taps}
Since the LoD is a function of the physico-chemical properties of the biosensor and of the interaction of the biosensor with
the biological sample, we abstracted the biological entities present in the sample as well as those grafted to the sensor’s gate.
These entities here include the ATP nucleotide – our target biomarker – and its ABL tyrosine-kinase receptor. Although we did
not require to develop a complete biomolecular taxonomy to classify these two molecules it is clear that the modelling of CBPS
addressing hundreds or thousands of chemical and biological compounds would have compelled us to do to. As an illustration
of what such a taxonomy may look like we derived the elementary classifications relevant to ATP and ABL-tyrosine kinase.
ATP can be defined as a specialization of the Ligand class, and ABL-tyrosine kinase can be considered a specialization of
the Receptor class (figure 3). Both of these generic classes fall under the same direct generalization class: Molecule (NB:
ATP is not a protein-ligand, hence the most direct generalization goes to Molecule and not Protein).
In a similar fashion we abstracted the architecture of our LOC and HWA. We decomposed them into parts specified at
gradually lower-level of abstraction We proceeded down to the level where the elementary properties affecting the LoD
emerged. Examples of such properties are presented for the SiNW-bioFET sensor in figure 4. They include the SiNW length,
width, etc. The components or aggregations of components (i.e. sub-systems) constituting the LOC and HWA were at first
specified as what we call generic entities (see the Generic packages under LOC and HWA & Embedded SW in figure 3).
These generic models made sense early on in the modelling process as the architectural details for the LOC and HWA were
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unknown. We modelled the specific sub-systems or components once enough architectural details were known. We specified
the generalization relationships existing between the generic and specific parts and then replaced generic parts by their specific
counter parts. This is for instance illustrated in figure 3 with the Point-of-Care Hardware Accessory (POC HWA) aggregating a
Bluetooth Low Energy module (BLE112), the latter itself representing a specific implementation of a HWA communication
module.
3) Functions: We modelled the system’s functions influencing the LoD specification using the same abstraction and
decomposition steps we had followed for specifying the model’s structures. The highest-level functional view of the system is
provided by figure 4, which reveals the first-level functional decomposition of the SiNW-instrumentation system. The SiNW
Chip Instrumentation engulfs the Biological Sample in which the target analyte is present, the SiNW-bioFET
sensor, and the Lock-in amplifier (Lock-in amp) function. The scope of our analysis could thus be confined to the SiNW
Chip Instrumentation block. Once all the structures and functions composing or nested in this block were defined, we
could proceed to the parametric specification of all sub-systems and parts of interest.
4) Parametric relationships: We mathematically represented both the laws governing the physical interactions at the sam-
ple/biosensor level and the signal processing and computational steps influencing the system LoD using parametric diagrams.
We started by defining these laws at the lowest levels (most fundamental level of abstraction: the component level followed
by the sub-system level). Figure 5, for instance, represents the most elementary parametric relations governing the physical
behaviour of the gate of the SiNW-bioFET sensor. Each constraint block calls a Mathematica function responsible for calculating
the value of the fundamental properties derived from gate properties.
Using a bottom-up approach, we relied on these low-level parametric relations to progressively establish the mathemat-
ical laws defining the property values of sub-systems at higher abstraction levels. For instance, the parametric specifica-
tion of the Root Mean Square (RMS) noise level at the output of the Current Amplifier Stage block, held in the
VnoiseOutRmsSigCond property, could be defined by successively summing the individual noise contributions of the three
main blocks of the Current Amplifier Stage (i.e. AD8608 amplifier, the RC filter and the ADC) (figure 6). The
VnoiseOutRmsSigCond could similarly be leveraged one level up in the structural/functional hierarchy within the Lock-in
amp function as the latter itself nests the Current Amplifier Stage block (figure 7), etc. This strategy ended with the
specification of the parametric specification of the highest abstraction level, that of the SiNW Chip Instrumentation
function (figure 8). There the LoD value property could be calculated, together with the signal amplitude values needed to
ascertain that no signal saturation i.e. constraint violation would occur.
5) Parametric study: Once our model was completed, we set up a trade study using the Paramagic plugin by defining sets of
specification values for parameters we deemed should be most relevant to investigate if we were to upgrade system components
in isolation in an attempt to reach a lower system LoD specification. By isolation we mean that a component swap or upgrade
would likely not cascade into further needed changes throughout the rest of the system. The parameters we selected span over
all the engineering disciplines involved in the definition of the system-level LoD: surface chemistry, microfabrication, analog
electronics and digital signal processing. These parameters are highlighted in bold in Table I. We considered 8 SiNW thickness
alternatives, from 20 to 90 nm, 4 different SiNW gate thicknesses, 6 possible SiNW gate receptors surface coverage densities,
4 possible specifications for the input amplifier’s current noise density, 2 possible gains for this input amplifier, 2 possible
resolutions for the Analog to Digital Converter (ADC), 6 different Finite Impulse Response (FIR) digital filters. We therefore
investigated a design space containing 8× 4× 6× 4× 2× 2× 6 = 18432 points. The trade-study was set and executed within
the MagicDraw environment, importing and exporting variable values from and to Microsoft Excel. We used Matlab to display
the results presented in the following section.
VI. RESULTS
Adopting a systemic perspective on the SiNW-bioFET/instrumentation assembly turned out to be crucial in identifying which
sub-systems, and thus engineering domains, influence the most the LoD specification. Our parametric study shows the relative
influence of couples of parametric variables on the LoD. In figure 9, the LoD is investigated as a function of SiNW thickness
and gate surface receptors density respectively. Here it is evident that the predominant influence on LoD is surface chemistry.
A similar trend is seen in figure 10 where the LoD is plotted versus SiNW gate oxide thickness and gate surface receptors.
The availability of such result should therefore encourage sensor fabrication specialists and surface chemists to agree on a
design trade-off taking into consideration the relative difficulties associated with the thinning of sensor structures down to a
few nanometers versus the small LoD performance enhancement one may hope to achieve from it.
Also, our system-wide investigation highlights limitations that could not be anticipated by the investigation of the biosensor
alone: the apparent non-linear influence of the SiNW thickness in figure 11 is not predicted by existing analytical models
for SiNW-bioFETs. Rather, this behaviour results from the complex interactions between SiNW-bioFET and instrumentation.
Figure 11 highlights the balance between antagonists trends: towards greater sensor LoD performances on one end and poorer
instrumentation LoD performances on the other end. Figure 11 also reveals some of the systemic configurations to avoid:
when the gate oxide thickness is 2 nm no LoD can be computed, i.e. where there was no instrument configuration providing
a sufficient Signal to Noise ratio.
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Fig. 4. SiNW instrumentation functional decomposition and function allocation
Beside the identification of emergent systemic behaviours, we were able to predict the extent of performance enhancement
we thought we could obtain by changing the input amplifier for a variant specified with a lower current noise density. We thus
expected a lower amount of noise injected by the amplifier to translate into better LoD performances. Figure 12 alas reveals
the negligible influence of the amplifier’s current noise specification against the SiNW thickness. The latter parameter already
playing a small role in LoD specification, the input amplifier current noise can be neglected.
Finally, and most importantly, figure 13 reveals the relative influence of the gate surface receptor density versus the influence
of the efficiency of the digital filtering block, here represented by the number of taps of the various filters available in the
Post-Process block (figure 7). This observation thereby allows us to link the two most remote engineering domains
involved in the definition of the system-level LoD: surface chemistry on one side, and digital signal processing on the other.
An important observation here is that there seem to be system configurations for which filter selection or filter re-design could
help avoid the painstaking reengineering of the sensor’s biofunctionalization layer. Indeed, it appears that among the available
filters, selecting the 137-tap filter instead of any other can in some instances benefit the system-level LoD performance to a
similar extent as to improving the gate surface coverage by half an order of magnitude. This characteristic can be explained
by the design methods used to specify these filters [47] and will not be detailed here. The implications of this latter finding
are substantial: contrary to the foreseeable difficulties in remodelling the gate surface chemistry, digital filters can easily be
optimized at negligible costs and without any need for significant structural or behavioural alteration at the system-level.
VII. DISCUSSION AND CONCLUSION
The emergence of CPS harnessing biomolecular-scale components brings exciting opportunities for the advance of medicine
and environmental-sciences. The translation of innovative concepts to successful applications will yet require designing organ-
isations to address safety, efficacy and cost-efficiency challenges that concern both expert and public opinion. The adoption of
appropriate MBSD frameworks can support designing organisations in that attempt, by enabling the design and analysis of CBPS
spanning across the biological, physical-non-biological and computational domains, while streamlining product development.
Here, we demonstrated in particular that formalisms of the SysML language can be harnessed in the early phases of
CBPS design by: 1– modelling a complete in vitro diagnostic system; 2– illustrating the possibility to carry out system-wide
OPEN-ACCESS 11
Fig. 5. Low-level parametric diagram for the gate of the SiNW-bioFET sensor
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performance analyses on that model and, from those: 3– identifying system-level bottlenecks to system performance indicating
which system modules should be targeted first for optimization.
From such endeavours, it is also straightforward to assume the feasibility of formal performance requirements verification
since SysML allows for requirements and specification traceability. Likewise, we may conjecture that other tools of MBSD may
further strengthen the legitimacy of the approach: Design Structure Matrices and change-propagation analyses are becoming
standard tools of SysML-based MBSD [49]–[51]. These can help trace dependencies, plan for system upgrade or redesign and
perhaps support the re-thinking of functional allocation even for the largest of CBPS currently existing (e.g. bench-size clinical
IVMT analyzers).
Questions now arise as to the extent to which available MBSD frameworks can support designing organisations throughout the
remainder of the system development process. Although we showed that early modelling and analyses paved the way for formal
verification methods, the integration of these practices into an engineering framework tightly coupled with quality management
and regulatory affairs is another issue that will require further research. Also, even though the modelling capabilities offered by
SysML supposedly allow the modelling and in silico analysis of CBPS of greater complexity (e.g. such as of those more closely
associated with the low-level manipulation of biomolecules like automated synthetic biology instruments) we must reflect on the
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missing integrations between current SysML tools and design tools for hardware components and for chemical and biological
synthesis. Only when such integrations are available will design synthesis of CBPS be made possible. Indeed, although code-
generation from early abstract CPS SysML models has been demonstrated for computation-only embedded systems, there seems
to be a long way until the same principles enable the specification of CBPS where the functions, performance and constraints
imposed by a designer would be translated automatically into not only machine-code but also mechanical specifications and
biopolymer sequences (e.g. DNA). This visionary portrait of fully synthesized CBPS therefore extends our current vision of
the holy grail of CPS design.
Despite its current limitations, MBSD and in particular SysML provide designing organisations with a stepping-stone towards
the design of safe and cost-efficient CBPS. Advances in CPS MBSE will keep on benefiting those organisations who may soon
be capable not only to undertake software and hardware co-design but also to investigate the trade-offs involving elements of
a biological nature. Such developments promise the streamlining of CBPS development and encourage researchers to work on
the matter.
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